 Eric Enemark
Concepts (116)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Archaeal Proteins | 4 | 2022 | 15 | 2.430 |
Why?
| | Sulfolobus solfataricus | 4 | 2022 | 21 | 2.360 |
Why?
| | DNA Replication | 7 | 2022 | 150 | 1.840 |
Why?
| | DNA Helicases | 5 | 2022 | 144 | 1.780 |
Why?
| | Protein Multimerization | 5 | 2021 | 50 | 1.590 |
Why?
| | Adenosine Triphosphatases | 5 | 2022 | 87 | 1.220 |
Why?
| | Adenosine Triphosphate | 5 | 2022 | 230 | 1.130 |
Why?
| | Archaea | 2 | 2016 | 12 | 1.070 |
Why?
| | DNA-Binding Proteins | 5 | 2015 | 418 | 1.040 |
Why?
| | Models, Molecular | 12 | 2016 | 336 | 1.040 |
Why?
| | Pyrococcus furiosus | 4 | 2016 | 4 | 0.910 |
Why?
| | Crystallography, X-Ray | 8 | 2021 | 148 | 0.890 |
Why?
| | DNA, Single-Stranded | 3 | 2015 | 88 | 0.820 |
Why?
| | DNA, Archaeal | 2 | 2019 | 12 | 0.710 |
Why?
| | Viral Proteins | 4 | 2014 | 161 | 0.680 |
Why?
| | Bovine papillomavirus 1 | 3 | 2006 | 12 | 0.660 |
Why?
| | RNA | 2 | 2022 | 167 | 0.650 |
Why?
| | Amino Acid Sequence | 7 | 2021 | 582 | 0.630 |
Why?
| | Zinc | 1 | 2016 | 53 | 0.520 |
Why?
| | Mutation | 4 | 2019 | 1290 | 0.510 |
Why?
| | Medulloblastoma | 1 | 2015 | 17 | 0.490 |
Why?
| | DEAD-box RNA Helicases | 1 | 2015 | 31 | 0.480 |
Why?
| | Conserved Sequence | 1 | 2014 | 56 | 0.460 |
Why?
| | DNA | 4 | 2021 | 539 | 0.460 |
Why?
| | Binding Sites | 6 | 2022 | 373 | 0.420 |
Why?
| | Crystallization | 3 | 2021 | 31 | 0.370 |
Why?
| | Protein Conformation | 3 | 2016 | 165 | 0.360 |
Why?
| | Molecular Sequence Data | 6 | 2014 | 791 | 0.360 |
Why?
| | Translocation, Genetic | 2 | 2022 | 263 | 0.330 |
Why?
| | Hydrolysis | 3 | 2022 | 62 | 0.310 |
Why?
| | Molecular Motor Proteins | 1 | 2008 | 9 | 0.310 |
Why?
| | Protein Binding | 4 | 2022 | 653 | 0.300 |
Why?
| | RNA Helicases | 1 | 2008 | 29 | 0.300 |
Why?
| | Protein Subunits | 2 | 2021 | 78 | 0.250 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2016 | 20 | 0.250 |
Why?
| | Adenosine Diphosphate | 2 | 2014 | 21 | 0.190 |
Why?
| | Virus Replication | 1 | 2002 | 138 | 0.180 |
Why?
| | Nucleic Acid Conformation | 2 | 2014 | 83 | 0.180 |
Why?
| | Protein Structure, Tertiary | 3 | 2014 | 251 | 0.170 |
Why?
| | Kinetics | 2 | 2022 | 627 | 0.170 |
Why?
| | Leukemia, Erythroblastic, Acute | 1 | 2019 | 4 | 0.170 |
Why?
| | Recombinant Fusion Proteins | 2 | 2014 | 185 | 0.160 |
Why?
| | Models, Biological | 3 | 2015 | 722 | 0.160 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 144 | 0.160 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2019 | 16 | 0.150 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2015 | 98 | 0.150 |
Why?
| | Cations, Divalent | 1 | 2016 | 6 | 0.140 |
Why?
| | Cloning, Molecular | 1 | 2016 | 184 | 0.130 |
Why?
| | Substrate Specificity | 1 | 2016 | 192 | 0.130 |
Why?
| | Plasmids | 1 | 2016 | 162 | 0.130 |
Why?
| | Multienzyme Complexes | 1 | 2015 | 34 | 0.130 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 30 | 0.120 |
Why?
| | Genetic Complementation Test | 1 | 2015 | 46 | 0.120 |
Why?
| | Escherichia coli | 1 | 2016 | 189 | 0.120 |
Why?
| | Cerebellar Neoplasms | 1 | 2015 | 23 | 0.120 |
Why?
| | Allosteric Regulation | 1 | 2014 | 13 | 0.120 |
Why?
| | Recombinant Proteins | 1 | 2016 | 488 | 0.120 |
Why?
| | Catalytic Domain | 1 | 2014 | 57 | 0.120 |
Why?
| | Animals | 6 | 2015 | 13133 | 0.120 |
Why?
| | Schizosaccharomyces | 1 | 2015 | 48 | 0.120 |
Why?
| | Gene Expression | 1 | 2016 | 613 | 0.110 |
Why?
| | Phenylurea Compounds | 1 | 2013 | 15 | 0.110 |
Why?
| | Niacinamide | 1 | 2013 | 22 | 0.110 |
Why?
| | Pyrroles | 1 | 2013 | 68 | 0.110 |
Why?
| | Saccharomyces cerevisiae | 1 | 2014 | 176 | 0.110 |
Why?
| | Protein Biosynthesis | 1 | 2015 | 250 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2013 | 179 | 0.100 |
Why?
| | Indoles | 1 | 2013 | 273 | 0.090 |
Why?
| | Cattle | 2 | 2002 | 216 | 0.090 |
Why?
| | Child | 3 | 2019 | 6838 | 0.080 |
Why?
| | Mice | 2 | 2015 | 5671 | 0.080 |
Why?
| | Apoproteins | 1 | 2006 | 14 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2006 | 27 | 0.070 |
Why?
| | Plasmodium falciparum | 1 | 2005 | 19 | 0.060 |
Why?
| | Antigens, Protozoan | 1 | 2005 | 10 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2005 | 32 | 0.060 |
Why?
| | Erythrocytes | 1 | 2005 | 83 | 0.060 |
Why?
| | Dimerization | 2 | 2005 | 50 | 0.060 |
Why?
| | Viral Nonstructural Proteins | 1 | 2022 | 56 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2002 | 57 | 0.050 |
Why?
| | Protein Structure, Secondary | 1 | 2002 | 71 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2022 | 302 | 0.050 |
Why?
| | Static Electricity | 1 | 2000 | 21 | 0.050 |
Why?
| | Tumor Virus Infections | 1 | 2000 | 41 | 0.040 |
Why?
| | Papillomaviridae | 1 | 2000 | 102 | 0.040 |
Why?
| | Humans | 5 | 2019 | 49863 | 0.040 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2019 | 14 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2019 | 79 | 0.040 |
Why?
| | Papillomavirus Infections | 1 | 2000 | 168 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2019 | 240 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2000 | 276 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2019 | 214 | 0.040 |
Why?
| | Genomics | 1 | 2019 | 284 | 0.040 |
Why?
| | Adolescent | 2 | 2019 | 6392 | 0.030 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2014 | 16 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2014 | 46 | 0.030 |
Why?
| | Prognosis | 1 | 2019 | 1948 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 66 | 0.030 |
Why?
| | Female | 3 | 2019 | 26520 | 0.030 |
Why?
| | Base Sequence | 1 | 2014 | 644 | 0.030 |
Why?
| | Alleles | 1 | 2013 | 251 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2013 | 205 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 2725 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 313 | 0.020 |
Why?
| | Infant | 1 | 2019 | 3565 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 3872 | 0.020 |
Why?
| | Young Adult | 1 | 2019 | 4013 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 1387 | 0.020 |
Why?
| | Male | 2 | 2019 | 25439 | 0.020 |
Why?
| | Rosette Formation | 1 | 2005 | 2 | 0.020 |
Why?
| | Erythrocyte Membrane | 1 | 2005 | 14 | 0.020 |
Why?
| | COS Cells | 1 | 2005 | 74 | 0.020 |
Why?
| | Polysaccharides | 1 | 2005 | 51 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 1173 | 0.020 |
Why?
| | Adult | 1 | 2019 | 13325 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2013 | 5165 | 0.010 |
Why?
|
|
Enemark's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|